Metraipolis › archive › dc_69fd665eed48
Immunomodulatory biomaterials as a novel therapeutic platform for inflammatory bowel disease — Europe PMC PMID:42466442
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42466442
- DOI
- 10.1177/17562848261463601
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T07:12:59.308Z
- SHA-256 of the archived text
f5ffd18035cff5b111c98811ae0fac07ea1eac3b39ef5c9436ae8bbd60ea902f- Stable URL of this page
https://metraipolis.com/documento/dc_69fd665eed48
How to cite
Immunomodulatory biomaterials as a novel therapeutic platform for inflammatory bowel disease — Europe PMC PMID:42466442 — Europe PMC (en), https://europepmc.org/article/MED/42466442 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_69fd665eed48 (Metraipolis archive dc_69fd665eed48, sha256 f5ffd18035cff5b111c98811ae0fac07ea1eac3b39ef5c9436ae8bbd60ea902f)
BibTeX
@misc{dc69fd665eed48,
title = {Immunomodulatory biomaterials as a novel therapeutic platform for inflammatory bowel disease — Europe PMC PMID:42466442},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42466442},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_69fd665eed48; sha256 f5ffd18035cff5b111c98811ae0fac07ea1eac3b39ef5c9436ae8bbd60ea902f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42466442. Agents can read the archived copy with the MCP tool read_document.